The new coronavirus that causes coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused significant morbidity and mortality.
A hypothetical third wave, according to the World Health Organization and the All India Institute of Medical Sciences, will not have a disproportionate impact on children.
This result is based on a seroprevalence study done in five states with a sample size of 10,000 individuals. Covid-19 seroprevalence in individuals under the age of 18 is 55.7 percent, and 63.5 percent in those over the age of 18.
Children will not be disproportionately affected in the third wave, as originally expected, because they have the same amount of antibodies.
Many people have developed resistance to Covid-19 in general
SARS-CoV-2 infection and severe clinical symptoms are risk factors for children of all ages. Although the majority of COVID-19 cases in children are asymptomatic or moderate, 18.4/100,000 children aged 0–4 and 10.6/100,000 children aged 5–17 require hospitalization, with one-third requiring intensive care.
Age extremes, such as infancy and late adolescence, are risk factors for hospitalization. Medical comorbidities, such as medical complexity, immunocompromising diseases, and obesity, are risk factors for intensive care admission.
Although children with pre-existing medical problems are obviously predisposed to severe illness, previously healthy youngsters are equally at risk for severe COVID-19 and multisystem inflammatory syndrome in children (MIS-C). Complications of MIS-C include cardiac dysfunction, shock, and respiratory failure that necessitates urgent care.
Furthermore, pediatric vaccinations are likely to be required to limit SARS-CoV-2 transmission. Children spread a variety of respiratory and gastrointestinal infections, such as influenza, pneumococcus, rotavirus, and hepatitis A.
Following the adoption of regular pediatric immunization with PCV7 in 2000 and PCV13 in 2010, both children and adults had substantial decreases in invasive pneumococcal illness. As a result, there is a compelling case to be made for childhood immunization decreasing community transmission, and avoiding adult illness.
● COVID-19 vaccinations were created utilizing research that has been available for a long time.
● COVID-19 vaccinations are not being tested. They passed through all of the clinical trial stages. Extensive testing and monitoring have demonstrated that these vaccinations are both safe and efficacious.
● COVID-19 vaccines have been subjected to, and continue to be subjected to, the most stringent safety monitoring.
● Regardless of whether you have previously had COVID-19, get vaccinated. Vaccination has been found in studies to offer a significant increase in protection in persons who have recovered from COVID-19.
● People who had been treated for COVID-19 with monoclonal antibodies or convalescent plasma, or who had a history of multisystem inflammatory syndrome in adults or children, were included in the study (MIS-A or MIS-C).
● Unvaccinated persons are still at risk from COVID-19. Some persons who get COVID-19 may become seriously sick, necessitating hospitalization, while others may experience long-term health issues several weeks or even months after becoming infected. Even those who did not have symptoms when infected can develop these long-term health issues.
The Bottom line
Getting yourself vaccinated is the safest way out of this reckless situation. So get the vaccine when you get your chance
A motivated student of Medicine & Surgery (MBBS) at R. G. Kar Medical College & Hospital, Kolkata, having a knack for reading and composing medical literature. When he's not writing content for MEDtalks, Swapnil is usually looking up the latest trends and innovations in Medicine.